Developer docs
API playgroundTry for free, no card

Search company profiles

Biolytica

Full company profile

uuid0002g5d

Namestring
Biolytica
Legal namestring
Biolytica
Websiteurl
biolytica.com
Company typeenum
Private
Founded yearint
2023
Descriptiontext

Biolytica is a Swiss health data company that has built NEXUS, an AI-driven platform designed to integrate diverse biological and lifestyle data into actionable health insights for preventive healthcare and longevity use cases. The company is headquartered in Switzerland (Zug/Zurich), was founded in 2021, and operates with a workforce of 11-50 employees. Its target customers span three B2B segments: healthcare providers (hospitals and clinics seeking integrated patient data), insurance companies (using biological data for risk assessment and wellness-linked products), and wellness clinics (delivering personalized client programs). The company pursues a horizontal segmentation approach across these verticals.

The NEXUS platform is the sole core product. Biolytica describes its underlying AI as generative_ai applied to consolidating fragmented biological and lifestyle data streams into health solutions; no proprietary models, patents, or third-party benchmarks are disclosed. The revenue model is subscription-based recurring, sold to enterprise B2B clients, but pricing is not publicly disclosed and no customer logos, case studies, or contract values have been disclosed in the available data.

Biolytica has raised a single seed round of CHF 5.25 million (approximately US$5.8 million) from the Maximon Longevity Co-Investment Fund in May 2023. The company stated an aspiration for mid-7-figure annual revenue by year-end 2023, but no actual revenue figure has been reported. Leadership comprises Dr. Rob Konrad Maciejewski (CEO) and Marc P. Bernegger (Founder). A material caveat: the company's primary web domain biolytica.com appears listed for resale on a third-party domain marketplace (Atom.com), which raises concerns about the company's control of its primary digital asset and warrants verification in any diligence process.

Short descriptiontext

Biolytica is a Swiss health data company that has built NEXUS, an AI-driven platform integrating biological and lifestyle data into preventive healthcare and longevity solutions for healthcare providers, insurance carriers, and wellness clinics on a subscription basis.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersZug, Switzerland
HQ citystring
Zug
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
health data platform, longevity analytics, preventive health software, biological data integration, AI health insights
Industry3 codes
PRIMARYHLALAFAL
Multi-Condition RPM Platforms & Care Orchestration (device-agnostic, population management)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLACAFAJ
Patient App, Adherence & Engagement for RPM Programs
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLACAFAD
Behavioral Health & Substance Use Remote Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
NAICS code2 codes
  • Social Assistance624
  • Outpatient Mental Health and Substance Abuse Centers621420
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Health Services8000
Product category
Health Data Analytics Platform
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Data-driven health solutions
TypeSubscription Recurring
Description

Biolytica generates revenue by offering AI-driven data solutions to healthcare providers, insurance companies, and wellness clinics. The platform integrates biological and lifestyle data to provide actionable health insights.

linkedin.com
Cost components4 values
Technology or R&D, Personnel, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1NEXUS
Description

AI-driven health data platform that integrates diverse biological and lifestyle data to generate solutions for healthcare providers, insurance companies, and wellness clinics, with focus on preventive healthcare and longevity.

linkedin.com
Core offering1 text field

Biolytica develops and sells NEXUS, an AI-driven health data platform that integrates diverse biological and lifestyle data to generate preventive healthcare and longevity solutions. The platform is offered to healthcare providers, insurance companies, and wellness clinics to support personalized health insights, risk assessment, and wellness program design. Revenue is generated via a subscription-based recurring model targeted at B2B customers.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Biolytica offers a single unified AI-driven health data platform called NEXUS. The platform integrates diverse biological and lifestyle data to generate solutions for healthcare providers, insurance companies, and wellness clinics, with a focus on preventive healthcare and longevity.

Product and service1 record
1NEXUS
CategoryHealth Data Analytics Platform
Description

AI-driven health data platform that integrates diverse biological and lifestyle data to generate solutions for healthcare providers, insurance companies, and wellness clinics, focused on preventive healthcare and longevity.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1Function Health
TypeDirect peer
Description

Function Health is a direct competitor offering membership-based preventive health with comprehensive blood biomarker testing and AI-driven insights — very similar to Biolytica's value proposition of integrating biological data for personalized health optimization.

TypeDirect peer
Description

InsideTracker integrates blood, DNA, wearable, and lifestyle data to deliver personalized health and longevity recommendations. It is one of the closest direct peers to Biolytica's NEXUS platform in terms of integrating diverse biological data sources for preventive insights.

TypeDirect peer
Description

Viome uses AI to analyze microbiome and other biological data to generate personalized nutrition and health recommendations. It competes directly in the AI-driven, data-aggregated preventive health space where Biolytica plays.

TypeBroad incumbent
Description

Thorne combines supplements with at-home health testing and a digital platform to deliver personalized wellness. It overlaps with Biolytica in the longevity/preventive health data space but operates a much broader product portfolio including supplements.

TypeDirect peer
Description

Prenuvo offers whole-body MRI screening combined with AI-driven health insights for preventive and longevity-focused consumers. It competes with Biolytica for the same health-conscious, data-driven preventive health customer base.

TypeDirect peer
Description

Fountain Life provides AI-enabled preventive health diagnostics and longevity-focused health programs. It is a direct competitor in the preventive/longevity health data and diagnostics space, with similar target customers.

TypeBroad incumbent
Description

Human Longevity Inc. offers comprehensive genomic and clinical data integration for longevity-focused preventive health. It is a more established incumbent with broader capabilities than Biolytica in the same longevity/health-data aggregation space.

TypeBroad incumbent
Description

23andMe is a consumer genetic testing company that has expanded into health-risk reporting and research platforms based on aggregated genetic data. It is comparable to Biolytica in the consumer-facing biological data aggregation model, though focused narrowly on genomics.

TypeEmerging player
Description

Elysium Health develops longevity-focused supplements and consumer health products grounded in cellular biology research. It is a partial peer — operating in the longevity space with a different monetization model (products vs. data platform) but targeting overlapping consumers.

TypeEmerging player
Description

Ezra offers AI-powered full-body MRI screening for early cancer detection and preventive health. It overlaps with Biolytica's preventive/longevity positioning but is narrower in scope (imaging-focused).

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Biolytica

Health Data Analytics Platformbiolytica.com

Biolytica is a Swiss health data company that has built NEXUS, an AI-driven platform integrating biological and lifestyle data into preventive healthcare and longevity solutions for healthcare providers, insurance carriers, and wellness clinics on a subscription basis.

What Biolytica does

Biolytica is a Swiss health data company that has built NEXUS, an AI-driven platform designed to integrate diverse biological and lifestyle data into actionable health insights for preventive healthcare and longevity use cases. The company is headquartered in Switzerland (Zug/Zurich), was founded in 2021, and operates with a workforce of 11-50 employees. Its target customers span three B2B segments: healthcare providers (hospitals and clinics seeking integrated patient data), insurance companies (using biological data for risk assessment and wellness-linked products), and wellness clinics (delivering personalized client programs). The company pursues a horizontal segmentation approach across these verticals.

The NEXUS platform is the sole core product. Biolytica describes its underlying AI as generative_ai applied to consolidating fragmented biological and lifestyle data streams into health solutions; no proprietary models, patents, or third-party benchmarks are disclosed. The revenue model is subscription-based recurring, sold to enterprise B2B clients, but pricing is not publicly disclosed and no customer logos, case studies, or contract values have been disclosed in the available data.

Biolytica has raised a single seed round of CHF 5.25 million (approximately US$5.8 million) from the Maximon Longevity Co-Investment Fund in May 2023. The company stated an aspiration for mid-7-figure annual revenue by year-end 2023, but no actual revenue figure has been reported. Leadership comprises Dr. Rob Konrad Maciejewski (CEO) and Marc P. Bernegger (Founder). A material caveat: the company's primary web domain biolytica.com appears listed for resale on a third-party domain marketplace (Atom.com), which raises concerns about the company's control of its primary digital asset and warrants verification in any diligence process.

Biolytica firmographics

Firmographics
Name
Biolytica
Legal name
Biolytica
Website
https://biolytica.com
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
1–10 employees
Short description
Biolytica is a Swiss health data company that has built NEXUS, an AI-driven platform integrating biological and lifestyle data into preventive healthcare and longevity solutions for healthcare providers, insurance carriers, and wellness clinics on a subscription basis.
Ownership category
akta.pro rank

Biolytica industry classification

Industry
Product category
Health Data Analytics Platform
NAICS
Social Assistance (624), Outpatient Mental Health and Substance Abuse Centers (621420)
SIC
Services-Prepackaged Software (7372), Services-Health Services (8000)
akta.pro industry
PRIMARYHLALAFAL
Multi-Condition RPM Platforms & Care Orchestration (device-agnostic, population management)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLACAFAJ
Patient App, Adherence & Engagement for RPM Programs
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLACAFAD
Behavioral Health & Substance Use Remote Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms

Keywords

  • Health data platform
  • Longevity analytics
  • Preventive health software
  • Biological data integration
  • AI health insights

Where Biolytica is headquartered

Location

Headquarters

HQ city
Zug
HQ country
Switzerland
HQ region
Europe

Offices1 record

Markets served

Biolytica business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

  1. Data-driven health solutions: Biolytica generates revenue by offering AI-driven data solutions to healthcare providers, insurance companies, and wellness clinics. The platform integrates biological and lifestyle data to provide actionable health insights.

Go-to-market motion1 record

Biolytica product offering

Product offering

Core offering

Biolytica develops and sells NEXUS, an AI-driven health data platform that integrates diverse biological and lifestyle data to generate preventive healthcare and longevity solutions. The platform is offered to healthcare providers, insurance companies, and wellness clinics to support personalized health insights, risk assessment, and wellness program design. Revenue is generated via a subscription-based recurring model targeted at B2B customers.

Product overview

Biolytica offers a single unified AI-driven health data platform called NEXUS. The platform integrates diverse biological and lifestyle data to generate solutions for healthcare providers, insurance companies, and wellness clinics, with a focus on preventive healthcare and longevity.

Differentiator

Problem solved

Functional benefit

Brands

  • NEXUS: AI-driven health data platform that integrates diverse biological and lifestyle data to generate solutions for healthcare providers, insurance companies, and wellness clinics, with focus on preventive healthcare and longevity.

Products and services

  • NEXUS AI-driven health data platform that integrates diverse biological and lifestyle data to generate solutions for healthcare providers, insurance companies, and wellness clinics, focused on preventive healthcare and longevity.

Companies that use Biolytica

Customer profile

Segments3 records

Ideal customer profiles3 records

Biolytica technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature1 record

Biolytica partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Biolytica competitors and assessment

Company assessment

Direct peers

  • Function Health: Function Health is a direct competitor offering membership-based preventive health with comprehensive blood biomarker testing and AI-driven insights — very similar to Biolytica's value proposition of integrating biological data for personalized health optimization.
  • InsideTracker: InsideTracker integrates blood, DNA, wearable, and lifestyle data to deliver personalized health and longevity recommendations. It is one of the closest direct peers to Biolytica's NEXUS platform in terms of integrating diverse biological data sources for preventive insights.
  • Viome Life Sciences: Viome uses AI to analyze microbiome and other biological data to generate personalized nutrition and health recommendations. It competes directly in the AI-driven, data-aggregated preventive health space where Biolytica plays.
  • Prenuvo: Prenuvo offers whole-body MRI screening combined with AI-driven health insights for preventive and longevity-focused consumers. It competes with Biolytica for the same health-conscious, data-driven preventive health customer base.
  • Fountain Life: Fountain Life provides AI-enabled preventive health diagnostics and longevity-focused health programs. It is a direct competitor in the preventive/longevity health data and diagnostics space, with similar target customers.

Broad incumbents

  • Thorne HealthTech: Thorne combines supplements with at-home health testing and a digital platform to deliver personalized wellness. It overlaps with Biolytica in the longevity/preventive health data space but operates a much broader product portfolio including supplements.
  • Human Longevity Inc. Human Longevity Inc. offers comprehensive genomic and clinical data integration for longevity-focused preventive health. It is a more established incumbent with broader capabilities than Biolytica in the same longevity/health-data aggregation space.
  • 23andMe: 23andMe is a consumer genetic testing company that has expanded into health-risk reporting and research platforms based on aggregated genetic data. It is comparable to Biolytica in the consumer-facing biological data aggregation model, though focused narrowly on genomics.

Emerging players

  • Elysium Health: Elysium Health develops longevity-focused supplements and consumer health products grounded in cellular biology research. It is a partial peer — operating in the longevity space with a different monetization model (products vs. data platform) but targeting overlapping consumers.
  • Ezra: Ezra offers AI-powered full-body MRI screening for early cancer detection and preventive health. It overlaps with Biolytica's preventive/longevity positioning but is narrower in scope (imaging-focused).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat2 records

Key highlights6 records

Customer concentration

Biolytica social profiles

Digital presence

Biolytica financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Biolytica leadership team

Management profile

Number of profiles

Profiles2 records

Biolytica funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Biolytica M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biolytica

What does Biolytica do?

Biolytica develops and sells NEXUS, an AI-driven health data platform that integrates diverse biological and lifestyle data to generate preventive healthcare and longevity solutions. The platform is offered to healthcare providers, insurance companies, and wellness clinics to support personalized health insights, risk assessment, and wellness program design. Revenue is generated via a subscription-based recurring model targeted at B2B customers.

Is Biolytica a public or private company?

Biolytica is a private company. It is classified as venture growth investor backed and is currently operating.

When was Biolytica founded?

Biolytica was founded in 2023. It employs 1 to 10 people.

Where is Biolytica based?

Biolytica is headquartered in Zug, Switzerland, in the Europe region.

How does Biolytica make money?

One revenue line is on record: data-driven health solutions.

Who are Biolytica's main competitors?

Direct peers on record are Function Health, InsideTracker, Viome Life Sciences, Prenuvo and Fountain Life. Broad incumbents are Thorne HealthTech, Human Longevity Inc. and 23andMe. Emerging players are Elysium Health and Ezra.

Does Biolytica have an API?

No public API is recorded for Biolytica.

What industry is Biolytica in?

Biolytica's product category is Health Data Analytics Platform. Its primary akta.pro industry code is HLALAFAL, Multi-Condition RPM Platforms & Care Orchestration (device-agnostic, population management), with a secondary code of HLACAFAJ, Patient App, Adherence & Engagement for RPM Programs. Its NAICS code is 624 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals